RedHill Biopharma reported $-1.31 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Cara Therapeutics USD -0.59 4.45 Sep/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
Cronos Group USD 0.04 0.02 Mar/2026
RedHill Biopharma USD -1.31 33.38 Jun/2024